CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 75 of 90 entries

View as:

A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT05353010 Org: User:

Start: 05/01/22 End: 11/01/22 Due: 11/01/23

Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT04639804 Org: User:

Start: 06/06/20 End: 07/29/20 Due: 07/29/21

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT05723510 Org: User:

Start: 03/06/23 End: 07/24/23 Due: 07/24/24

Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia

Phase: N/A Priority: Normal

NCT ID: NCT02137993 Org: User:

Start: 03/31/12 End: 05/31/13 Due: 05/31/14

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

Phase: N/A Priority: Normal

NCT ID: NCT03847506 Org: User:

Start: 07/05/18 End: 12/02/20 Due: 12/02/21

To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra

Phase: N/A Priority: Normal

NCT ID: NCT01501435 Org: User:

Start: 12/31/11 End: 06/30/12 Due: 06/30/13

Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians

Phase: N/A Priority: Normal

NCT ID: NCT05005065 Org: User:

Start: 09/06/21 End: 11/30/21 Due: 11/30/22

Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT02060019 Org: User:

Start: 03/31/14 End: 12/31/14 Due: 12/31/15

Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg

Phase: N/A Priority: Normal

NCT ID: NCT02378441 Org: User:

Start: 02/28/15 End: 08/31/15 Due: 08/31/16

A Study to Compare the Pharmacokinetic Characteristics of CJ-12420

Phase: N/A Priority: Normal

NCT ID: NCT02995239 Org: User:

Start: 04/30/15 End: 04/30/15 Due: 04/30/16

A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects

Phase: N/A Priority: Normal

NCT ID: NCT04587011 Org: User:

Start: 09/24/20 End: 06/30/21 Due: 06/30/22

A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients

Phase: N/A Priority: Normal

NCT ID: NCT01370707 Org: User:

Start: 04/30/11 End: 07/31/12 Due: 07/31/13

to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT01926548 Org: User:

Start: 02/29/12 End: 06/30/12 Due: 06/30/13

Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin

Phase: N/A Priority: Normal

NCT ID: NCT01925300 Org: User:

Start: 07/31/13 End: 09/30/13 Due: 09/30/14

Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis

Phase: N/A Priority: Normal

NCT ID: NCT00956098 Org: User:

Start: 02/28/06 End: 02/28/07 Due: 02/28/08

A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls

Phase: N/A Priority: Normal

NCT ID: NCT04494269 Org: User:

Start: 09/08/20 End: 12/31/23 Due: 12/31/24

A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn

Phase: N/A Priority: Normal

NCT ID: NCT05701540 Org: User:

Start: 03/24/23 End: 12/31/24 Due: 12/31/25

A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT05040880 Org: User:

Start: 07/08/21 End: 10/31/21 Due: 10/31/22

Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate

Phase: N/A Priority: Normal

NCT ID: NCT01845272 Org: User:

Start: 04/30/13 End: 08/31/13 Due: 08/31/14

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer

Phase: N/A Priority: Normal

NCT ID: NCT02761512 Org: User:

Start: 05/31/16 End: 12/28/18 Due: 12/28/19

Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean Subjects

Phase: N/A Priority: Normal

NCT ID: NCT04486157 Org: User:

Start: 03/18/21 End: 05/10/21 Due: 05/10/22

Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy

Phase: N/A Priority: Normal

NCT ID: NCT01062139 Org: User:

Start: 10/31/09 End: - Due: -

Bioequivalence Study of CJ-30060 in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT03757390 Org: User:

Start: 11/09/18 End: 12/14/18 Due: 12/14/19

A Phase 1 Study of Tegoprazan on Healthy Male Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT03530228 Org: User:

Start: 05/31/18 End: 08/31/18 Due: 08/31/19

Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects

Phase: N/A Priority: Normal

NCT ID: NCT02069821 Org: User:

Start: 03/31/14 End: 07/31/14 Due: 07/31/15

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers	NCT05353010	HK inno.N Corporation	user2@example.com	None	2022-05-01	2022-11-01	2023-11-01	-	-	2025-07-14
Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers	NCT04639804	HK inno.N Corporation	user2@example.com	None	2020-06-06	2020-07-29	2021-07-29	-	-	2025-07-14
PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers	NCT05723510	HK inno.N Corporation	user2@example.com	None	2023-03-06	2023-07-24	2024-07-24	-	-	2025-07-14
Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia	NCT02137993	HK inno.N Corporation	user2@example.com	None	2012-03-31	2013-05-31	2014-05-31	-	-	2025-07-14
Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets	NCT03847506	HK inno.N Corporation	user2@example.com	None	2018-07-05	2020-12-02	2021-12-02	-	-	2025-07-14
To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil Supra	NCT01501435	HK inno.N Corporation	user2@example.com	None	2011-12-31	2012-06-30	2013-06-30	-	-	2025-07-14
Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians	NCT05005065	HK inno.N Corporation	user2@example.com	None	2021-09-06	2021-11-30	2022-11-30	-	-	2025-07-14
Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects	NCT02060019	HK inno.N Corporation	user2@example.com	None	2014-03-31	2014-12-31	2015-12-31	-	-	2025-07-14
Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg	NCT02378441	HK inno.N Corporation	user2@example.com	None	2015-02-28	2015-08-31	2016-08-31	-	-	2025-07-14
A Study to Compare the Pharmacokinetic Characteristics of CJ-12420	NCT02995239	HK inno.N Corporation	user2@example.com	None	2015-04-30	2015-04-30	2016-04-30	-	-	2025-07-14
A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects	NCT04587011	HK inno.N Corporation	user2@example.com	None	2020-09-24	2021-06-30	2022-06-30	-	-	2025-07-14
A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients	NCT01370707	HK inno.N Corporation	user2@example.com	None	2011-04-30	2012-07-31	2013-07-31	-	-	2025-07-14
to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers	NCT01926548	HK inno.N Corporation	user2@example.com	None	2012-02-29	2012-06-30	2013-06-30	-	-	2025-07-14
Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin	NCT01925300	HK inno.N Corporation	user2@example.com	None	2013-07-31	2013-09-30	2014-09-30	-	-	2025-07-14
Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis	NCT00956098	HK inno.N Corporation	user2@example.com	None	2006-02-28	2007-02-28	2008-02-28	-	-	2025-07-14
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls	NCT04494269	HK inno.N Corporation	user2@example.com	None	2020-09-08	2023-12-31	2024-12-31	-	-	2025-07-14
A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn	NCT05701540	HK inno.N Corporation	user2@example.com	None	2023-03-24	2024-12-31	2025-12-31	-	-	2025-07-14
A Bioequivalence Study Between Telmione Plus 80/12.5mg and Micardis Plus 80/12.5 mg in Healthy Adult Volunteers	NCT05040880	HK inno.N Corporation	user2@example.com	None	2021-07-08	2021-10-31	2022-10-31	-	-	2025-07-14
Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate	NCT01845272	HK inno.N Corporation	user2@example.com	None	2013-04-30	2013-08-31	2014-08-31	-	-	2025-07-14
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer	NCT02761512	HK inno.N Corporation	user2@example.com	None	2016-05-31	2018-12-28	2019-12-28	-	-	2025-07-14
Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean Subjects	NCT04486157	HK inno.N Corporation	user2@example.com	None	2021-03-18	2021-05-10	2022-05-10	-	-	2025-07-14
Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy	NCT01062139	HK inno.N Corporation	user2@example.com	None	2009-10-31	-	-	-	-	2025-07-14
Bioequivalence Study of CJ-30060 in Healthy Volunteers	NCT03757390	HK inno.N Corporation	user2@example.com	None	2018-11-09	2018-12-14	2019-12-14	-	-	2025-07-14
A Phase 1 Study of Tegoprazan on Healthy Male Volunteers	NCT03530228	HK inno.N Corporation	user2@example.com	None	2018-05-31	2018-08-31	2019-08-31	-	-	2025-07-14
Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects	NCT02069821	HK inno.N Corporation	user2@example.com	None	2014-03-31	2014-07-31	2015-07-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance